Solazyme, Inc. Proposes $100 Million IPO and Nasdaq Global Market Listing
3/14/2011 10:47:12 AM
GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--On March 11, 2011, one of Keating Capital, Inc.’s portfolio companies, Solazyme, Inc., filed an S-1 registration statement to go public through a $100 million initial public offering of its common stock. Solazyme intends to list its shares on the Nasdaq Global Market under the symbol "SZYM." Morgan Stanley and Goldman, Sachs & Co. are acting as lead underwriters.